Patents by Inventor Kenya Akada

Kenya Akada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release oral preparations
    Publication number: 20070116763
    Abstract: An object of the present invention is to provide a pharmaceutical preparation containing the drug as an active ingredient, which is capable of improving the QOL and the compliance of the patient who doses the drug while avoiding any excessive increase in the plasma level of the drug by means of controlling the in vivo release rate of the drug and also by means of reducing the frequency of taking the drug.
    Type: Application
    Filed: December 28, 2005
    Publication date: May 24, 2007
    Inventors: Hiroyuki Yasuura, Kenya Akada, Shogo Izumi
  • Sustained release oral preparations
    Patent number: 7198803
    Abstract: Medicinal preparations containing a drug 2-amino-3-cyano-5-2(2-fluorophenyl) -4-methylpyrrole wherein the QOL and compliance of patients taking this drug can be improved and an unnecessary increase in the drug concentration in the plasma can be prevented by sustaining the release speed of the drug in vivo and lowering the administration frequency of the drug. That is, sustained release oral preparations containing 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole as the active ingredient.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: April 3, 2007
    Assignee: Nippon Shinyaku Co., Ltd.
    Inventors: Hiroyuki Yasuura, Kenya Akada, Shogo Izumi
  • Sustained release oral preparations
    Publication number: 20030044465
    Abstract: Medicinal preparations containing a drug 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole wherein the QOL and compliance of patients taking this drug can be improved and an unnecessary increase in the drug concentration in the plasma can be prevented by sustaining the release speed of the drug in vivo and lowering the administration frequency of the drug. That is, sustained release oral preparations containing 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole as the active ingredient.
    Type: Application
    Filed: September 11, 2002
    Publication date: March 6, 2003
    Inventors: Hiroyuki Yasuura, Kenya Akada, Shogo Izumi